ENHANCED ASSOCIATION OF PLASMINOGEN PLASMIN WITH LESIONAL EPIDERMIS OF BULLOUS PEMPHIGOID

被引:24
作者
GISSLER, HM
SIMON, MM
KRAMER, MD
机构
[1] INST IMMUNOL & SEROL IMMUNPATHOL,IM NEUENHEIMER FELD 305,W-6900 HEIDELBERG,GERMANY
[2] MAX PLANCK INST IMMUNBIOL,W-7800 FREIBURG,GERMANY
关键词
D O I
10.1111/j.1365-2133.1992.tb00127.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The distribution of plasminogen/plasmin, the central proteolytic component of the plasminogen activator/plasmin system was analysed in lesional skin of bullous pemphigoid by using monoclonal antibodies (MAbs) specific for distinct epitopes of the plasminogen/plasmin molecule. Four groups of MAbs were used: (i) MAbs HD-PG 1 and HD-PG 2, specific for epitopes associated with the lysine-binding sites I (kringle domain 1 + 2 + 3) and II (kringle domain 4) of plasminogen/plasmin, (ii) MAbs HD-PG 6 and HD-PG 7, specific for the lysine binding site I only, (iii) MAbs HD-PG 12 (formerly designated P 2) and HD-PG 18, specific for non-kringle domains of glu- and lys-plasminogen, and (iv) MAb HD-PG 13 which recognizes glu-plasminogen, only. The basal cell layers of normal skin consistently reacted with MAb HD-PG 12, whereas only faint staining was seen with the other MAbs in the same biopsies. In contrast, all anti-plasminogen/plasmin MAbs strongly stained lower and intermediate epidermal cell layers of fully developed bullous pemphigoid lesions.
引用
收藏
页码:272 / 277
页数:6
相关论文
共 29 条
[1]   UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - PROENZYME, RECEPTOR, AND INHIBITORS [J].
BLASI, F ;
VASSALLI, JD ;
DANO, K .
JOURNAL OF CELL BIOLOGY, 1987, 104 (04) :801-804
[2]   PURIFICATION AND CHARACTERIZATION OF A NOVEL, OLIGOMERIC, PLASMINOGEN KRINGLE 4 BINDING-PROTEIN FROM HUMAN PLASMA-TETRANECTIN [J].
CLEMMENSEN, I ;
PETERSEN, LC ;
KLUFT, C .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 156 (02) :327-333
[3]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266
[4]   CORRELATION OF EPIDERMAL PLASMINOGEN-ACTIVATOR ACTIVITY WITH DISEASE-ACTIVITY IN PSORIASIS [J].
FRAKI, JE ;
LAZARUS, GS ;
GILGOR, RS ;
MARCHASE, P ;
SINGER, KH .
BRITISH JOURNAL OF DERMATOLOGY, 1983, 108 (01) :39-44
[5]   IMMUNOHISTOCHEMICAL LOCALIZATION OF UROKINASE-TYPE AND TISSUE-TYPE PLASMINOGEN ACTIVATORS IN PSORIATIC SKIN [J].
GRONDAHLHANSEN, J ;
RALFKIAER, E ;
NIELSEN, LS ;
KRISTENSEN, P ;
FRENTZ, G ;
DANO, K .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 88 (01) :28-32
[6]  
HAJJAR KA, 1986, J BIOL CHEM, V261, P1656
[7]   PLASMIN INDUCES ACANTHOLYSIS IN SKIN ORGAN-CULTURES [J].
HUNZIKER, T ;
VASSALLI, JD .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1987, 279 (05) :341-346
[8]   PLASMINOGEN IS PRESENT IN THE BASAL LAYER OF THE EPIDERMIS [J].
ISSEROFF, RR ;
RIFKIN, DB .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1983, 80 (04) :297-299
[9]   EPIDERMAL PLASMINOGEN-ACTIVATOR IS ABNORMAL IN CUTANEOUS LESIONS [J].
JENSEN, PJ ;
BAIRD, J ;
MORIOKA, S ;
LESSIN, S ;
LAZARUS, GS .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1988, 90 (06) :777-782
[10]   UROKINASE AND TISSUE-TYPE PLASMINOGEN ACTIVATORS IN HUMAN KERATINOCYTE CULTURE [J].
JENSEN, PJ ;
JOHN, M ;
BAIRD, J .
EXPERIMENTAL CELL RESEARCH, 1990, 187 (01) :162-169